Please login to the form below

Not currently logged in
Email:
Password:

DS Biopharma promotes Dr Markus Weissbach

He moves to chief operating officer at the Irish drug discovery firm

Dr Markus Weissbach has been appointed chief operating officer at Irish drug discovery and development company DS Biopharma.

He previously served as the Dublin-based firm's medical director, which he joined after a spell running his own consultancy.

Prior to that his 25years in the pharma, biotech and CRO industries saw him hold senior roles that included chief medical officer (Europe) at Novartis Vaccines and Diagnostics, president of Icon Clinical Research (Europe) and director of clinical research and development at Takeda R&D (Europe).

Commenting on his new appointed, DS Biopharma's executive chairman Dr John Climax said: “I am delighted to welcome Dr Markus Weissbach into his new role within the DS team and I look forward to working with him in advancing the DS portfolio.”

14th September 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics